|
Volume 272, Number 40,
Issue of October 3, 1997
pp. 25168-25175
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Human Factor H Deficiency
MUTATIONS IN FRAMEWORK CYSTEINE RESIDUES AND BLOCK IN H PROTEIN
SECRETION AND INTRACELLULAR CATABOLISM
(Received for publication, April 17, 1997, and in revised form, June 24, 1997)
Bettina H.
Ault
,
Bela Z.
Schmidt
,
Natalie L.
Fowler
,
Clifford E.
Kashtan
¶
,
Alaa E.
Ahmed
,
Beth A.
Vogt
¶
and
Harvey R.
Colten
From the Department of Pediatrics, Washington
University School of Medicine, St. Louis, Missouri 63110, ¶ Department of Pediatrics, the University of
Minnesota, Minneapolis, Minnesota 55455, and Specialty
Laboratories, Inc., Santa Monica, California 90404
The synthesis and secretion of factor H, a
regulatory protein of the complement system, were studied in skin
fibroblasts from an H-deficient child who has chronic
hypocomplementemic renal disease. In normal fibroblasts, factor H
transcripts of 4.3 and 1.8 kilobase pairs (kb) encode a 155-kDa protein
containing short consensus repeat (SCR) domains 1-20 and a 45-kDa
protein which contains SCRs 1-7, respectively. The patient's
fibroblasts expressed normal amounts of the 4.3- and 1.8-kb messages
constitutively and after tumor necrosis factor- /interferon-
stimulation. Lysates of [35S]methionine-labeled
fibroblasts from the patient contained the 155- and 45-kDa H
polypeptides, but secretion of the 155-kDa protein was blocked; the
45-kDa protein was secreted with normal kinetics. The patient's plasma
lacked the 155-kDa protein but contained the small form of H. Moreover,
in fibroblasts the retained 155-kDa factor H protein was not degraded,
even after 12 h. Immunoflourescent staining and confocal
microscopic imaging of the patient's fibroblasts indicated that factor
H was retained in the endoplasmic reticulum. Sequence analysis of
reverse transcription-polymerase chain reaction products (the entire
coding region) and genomic DNA revealed a T1679C substitution on one
allele and a G2949A substitution on the other (C518R mutation in SCR 9 and C991Y mutation in SCR 16, respectively). Both mutations affect
conserved cysteine residues characteristic of SCR modules and therefore
predict profound changes in the higher order structure of the 155-kDa
factor H protein. These data provide the first description of a
molecular mechanism for factor H deficiency and yield important
insights into the normal secretory pathway for this and other plasma
proteins with SCR motifs.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A.-l. Stahl, F. Vaziri-Sani, S. Heinen, A.-C. Kristoffersson, K.-H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
Blood,
June 1, 2008;
111(11):
5307 - 5315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Caprioli and G. Remuzzi
A mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome
Nephrol. Dial. Transplant.,
February 1, 2008;
23(2):
462 - 465.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Alexander, Y. Wang, A. Chang, A. Jacob, A. W.M. Minto, M. Karmegam, M. Haas, and R. J. Quigg
Mouse Podocyte Complement Factor H: The Functional Analog to Human Complement Receptor 1
J. Am. Soc. Nephrol.,
April 1, 2007;
18(4):
1157 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Abrera-Abeleda, C Nishimura, J L H Smith, S Sethi, J L McRae, B F Murphy, G Silvestri, C Skerka, M Jozsi, P F Zipfel, et al.
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)
J. Med. Genet.,
July 1, 2006;
43(7):
582 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Appel, H. T. Cook, G. Hageman, J. C. Jennette, M. Kashgarian, M. Kirschfink, J. D. Lambris, L. Lanning, H. U. Lutz, S. Meri, et al.
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update
J. Am. Soc. Nephrol.,
May 1, 2005;
16(5):
1392 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Dragon-Durey, V. Fremeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, G. Deschenes, P. Coppo, W. Herman Fridman, and L. Weiss
Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases
J. Am. Soc. Nephrol.,
March 1, 2004;
15(3):
787 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hellwage, T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri
Complement C3b/C3d and Cell Surface Polyanions Are Recognized by Overlapping Binding Sites on the Most Carboxyl-Terminal Domain of Complement Factor H
J. Immunol.,
December 15, 2002;
169(12):
6935 - 6944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Hegasy, T. Manuelian, K. Hogasen, J. H. Jansen, and P. F. Zipfel
The Molecular Basis for Hereditary Porcine Membranoproliferative Glomerulonephritis Type II: Point Mutations in the Factor H Coding Sequence Block Protein Secretion
Am. J. Pathol.,
December 1, 2002;
161(6):
2027 - 2034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. CAPRIOLI, P. BETTINAGLIO, P. F. ZIPFEL, B. AMADEI, E. DAINA, S. GAMBA, C. SKERKA, N. MARZILIANO, G. REMUZZI, and M. NORIS
The Molecular Basis of Familial Hemolytic Uremic Syndrome: Mutation Analysis of Factor H Gene Reveals a Hot Spot in Short Consensus Repeat 20
J. Am. Soc. Nephrol.,
February 1, 2001;
12(2):
297 - 307.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Z. Schmidt, N. L. Fowler, T. Hidvegi, D. H. Perlmutter, and H. R. Colten
Disruption of Disulfide Bonds Is Responsible for Impaired Secretion in Human Complement Factor H Deficiency
J. Biol. Chem.,
April 23, 1999;
274(17):
11782 - 11788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. NORIS, P. RUGGENENTI, A. PERNA, S. ORISIO, J. CAPRIOLI, C. SKERKA, B. VASILE, P. F. ZIPFEL, and G. REMUZZI
Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: Role of Factor HAbnormalities
J. Am. Soc. Nephrol.,
February 1, 1999;
10(2):
281 - 293.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z.-B. Zhu, T. P. Atkinson, and J. E. Volanakis
A Novel Type II Complement C2 Deficiency Allele in an African-American Family
J. Immunol.,
July 15, 1998;
161(2):
578 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri
Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b
J. Biol. Chem.,
September 1, 2000;
275(36):
27657 - 27662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Alexander, B. K. Hack, P. N. Cunningham, and R. J. Quigg
A Protein with Characteristics of Factor H Is Present on Rodent Platelets and Functions as the Immune Adherence Receptor
J. Biol. Chem.,
August 17, 2001;
276(34):
32129 - 32135.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|